{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Monopar Therapeutics Inc."},"Symbol":{"label":"Symbol","value":"MNPR"},"Address":{"label":"Address","value":"1000 SKOKIE BOULEVARD,SUITE 350, WILMETTE, Illinois, 60091, United States"},"Phone":{"label":"Phone","value":"+1 847 388-0349"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of?Validive?for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin?for the treatment?of advanced soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for advanced cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers."},"CompanyUrl":{"label":"Company Url","value":"https://www.monopartx.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Andrew J. Cittadine","title":"Chief Operating Officer"},{"name":"Chandler Drew Robinson","title":"President, Chief Executive Officer & Director"},{"name":"Laura Kelly","title":"Director-Clinical Operations"},{"name":"Patrice P. Rioux","title":"Chief Medical Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}